Analyst Conference Summaries

Biotechnology Investor Aids


conference date: May 8, 2019 @ 5:00 AM Pacific Time

Moderna: mRNA Therapy Potential Worth Accumulating March 14, 2019 @ Seeking Alpha

Q4 2018
Q4 2018
March 6, 2019 May 8, 2019    

Moderna (MRNA) is a clinical-stage biotechnology company specializing in RNA based therapies.

Moderna web site



More Analyst Conference Pages:


Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2019 William P. Meyers